Protective effect and mechanism of Qishiwei Zhenzhu pills on cerebral ischemia-reperfusion injury via blood-brain barrier and metabonomics

被引:28
|
作者
Xu, Min [1 ]
Wu, Ruixia [1 ]
Liang, Yuan [1 ]
Fu, Ke [1 ]
Zhou, You [1 ]
Li, Xiaoli [1 ]
Wu, Lei [1 ]
Wang, Zhang [2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu 611137, Sichuan, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Coll Ethnomed, 1166 Liutai Ave, Chengdu 611137, Sichuan, Peoples R China
基金
中国博士后科学基金;
关键词
Qishiwei Zhenzhu pills; Cerebral ischemia-reperfusion injury; Blood-brain barrier; Neuroprotective effect; Gas chromatography-mass spectrometry; RAT MODEL; NEUROPROTECTION; ISCHEMIA/REPERFUSION; DISRUPTION; EXPRESSION; MANAGEMENT; LACTATE; STROKE; ROLES; VEGF;
D O I
10.1016/j.biopha.2020.110723
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Stroke is an acute cerebrovascular disease caused by the sudden rupture of cerebral blood vessels or vascular obstruction from brain tissue damage or dysfunction, thereby preventing blood flow into the brain. Cerebral ischemia-reperfusion injury (CI/RI), a common syndrome of ischemic stroke, is a complex pathological process whose physiological mechanism is still unclear. Qishiwei Zhenzhu pills (QSW), a famous Tibetan medicine preparation, has the effect of tranquilizing by heavy settling, dredging channels and activating collaterals, harmonizing Qi and blood, restoring consciousness, and inducing resuscitation. Here, we investigated the protective effect of QSW on CI/RI in rats and its potential mechanism. First, the volatile and liposoluble components in QSW were determined using gas chromatography-mass spectrometry (GC-MS). After 24 h of CI/RI, the neuroprotective effect was determined by evaluating the neurological function, cerebral infarction, histopathology, and blood-brain barrier (BBB) function. Immunofluorescence, real-time quantitative PCR (RT-qPCR), and western blot (WB) were used to detect the expression of matrix metalloproteinase 9 (MMP-9), claudin-5, and occludin. Finally, GCMS metabonomics was used to identify different metabolites and analyze metabolic pathways. The results showed that 88 volatile components and 63 liposoluble components were detected in QSW. Following the experimental stroke operation, it was observed that rats administered QSW pretreatment had improved neurological function, reduced infarct volume (P < 0.01), increased Nissl bodies (P < 0.05), improved histopathology, and reduced BBB disruption. Immunofluorescence, RT-qPCR, and WB results showed that MMP-9 level in the brain tissue of the QSW pretreatment group had a decreasing trend and the expression of claudin-5 and occludin had a tendency to increase. Eleven metabolites related to lipid metabolism, fatty acid metabolism, and energy metabolism, were identified via GC-MS metabonomics. Our study shows that QSW preconditioning has a neuroprotective effect on CI/RI; however, its mechanism requires further study.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Metabolomic Profiling of Brain Protective Effect of Edaravone on Cerebral Ischemia-Reperfusion Injury in Mice
    Ma, Hui-fen
    Zheng, Fan
    Su, Lin-jie
    Zhang, Da-wei
    Liu, Yi-ning
    Li, Fang
    Zhang, Yuan-yuan
    Gong, Shuai-shuai
    Kou, Jun-ping
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [32] Effect of ulinastatin on the permeability of the blood-brain barrier on rats with global cerebral ischemia/reperfusion injury as assessed by MRI
    Liu, Ming
    Shen, Jie
    Zou, Fan
    Zhao, Yunfeng
    Li, Bing
    Fan, Mingxia
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 412 - 417
  • [33] Neuroprotective Effect of Activated Protein C on Blood-Brain Barrier Injury During Focal Cerebral Ischemia/Reperfusion
    Wang, Jinqiao
    Rao, Gaofeng
    Ma, Yifan
    Zhang, Jingjing
    Shen, Jingjing
    Shi, Chaohong
    DOSE-RESPONSE, 2020, 18 (02):
  • [34] YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice
    Cao, Guosheng
    Ye, Xinyi
    Xu, Yingqiong
    Yin, Mingzhu
    Chen, Honglin
    Kou, Junping
    Yu, Boyang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 315 - 325
  • [35] Interleukin-35 attenuates blood-brain barrier dysfunction caused by cerebral ischemia-reperfusion injury through inhibiting brain endothelial cell injury
    Qian, Lei
    Li, Ming
    Lin, Xin
    Teng, Hongwei
    Yu, Lulu
    Jiang, Maorong
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (14)
  • [36] Ginseng aconitum decoction (Shenfu Tang) provides neuroprotection by ameliorating impairment of blood-brain barrier in cerebral ischemia-reperfusion injury
    Zhang, Wei
    Ren, Changhong
    Yang, Yu
    Xu, Jun
    Tong, Fang
    Wu, Xiaodan
    Yang, Yong
    BRAIN RESEARCH, 2024, 1842
  • [37] Expression of p-glycoprotein in the blood-brain barrier and its interaction with redox state in cerebral ischemia and ischemia-reperfusion
    Yakusheva E.N.
    Shchul’kin A.V.
    Chernykh I.V.
    Vinogradov I.Y.
    Neuroscience and Behavioral Physiology, 2017, 47 (6) : 661 - 666
  • [38] Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury
    Dimitrijevic, Oliver B.
    Stamatovic, Svetlana M.
    Keep, Richard F.
    Andjelkovic, Anuska V.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2006, 26 (06): : 797 - 810
  • [39] Protective effect of Danhong injection on cerebral ischemia-reperfusion injury in rats
    He, Yu
    Wan, Haitong
    Du, Yueguang
    Bie, Xiaodong
    Zhao, Tao
    Fu, Wei
    Xing, Panke
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 144 (02) : 387 - 394
  • [40] Investigation of the protective effect of anzer propolis in cerebral ischemia-reperfusion injury
    Toksoy, C. Koseoglu
    Sarita, Z. K.
    Boru, U. Turk
    Demiral, G. zeytin
    Gorucu, F.
    Bulbul, A.
    Demirel, H. H.
    Koc, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (17) : 8004 - 8012